SCHEMBL3435176

SCHEMBL3435176

N[C@@H](Cc1cnc[nH]1)C(=O)OO

nearest known ligand 0.69

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.69
SLC7A5 Q01650 1/20 0.69
HRH4 Q9H3N8 3/20 0.53
HRH3 Q9Y5N1 3/20 0.53
ALDH1A1 P00352 2/20 0.53
MEN1 O00255 1/20 0.53
GLA P06280 1/20 0.53
KMT2A Q03164 1/20 0.53
CYP1A2 P05177 1/20 0.53
NFKB1 P19838 1/20 0.53
THPO P40225 1/20 0.53
LMNA P02545 1/20 0.51
APEX1 P27695 1/20 0.51
BLM P54132 1/20 0.51
NLN Q9BYT8 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3434038 0.98 CYP3A4 (0.67) CYP3A4SLC7A5HRH4HRH3ALDH1A1
SCHEMBL388562 0.90 CYP3A4 (0.73) CYP3A4SLC7A5HRH4HRH3ALDH1A1
SCHEMBL1537285 0.89 CYP3A4 (0.71) CYP3A4SLC7A5HRH4HRH3ALDH1A1
SCHEMBL163444 0.89 CYP3A4 (0.71) CYP3A4SLC7A5HRH4HRH3ALDH1A1
SCHEMBL153062 0.87 CYP3A4 (0.69) CYP3A4SLC7A5HRH4HRH3ALDH1A1
Hydrochloric Acid SCHEMBL28331180 0.87 CYP3A4 (0.69) CYP3A4SLC7A5HRH4HRH3ALDH1A1
SCHEMBL3846866 0.86 CYP3A4 (0.67) CYP3A4SLC7A5HRH4HRH3ALDH1A1
SCHEMBL9898388 0.86 CYP3A4 (0.67) CYP3A4SLC7A5HRH4HRH3ALDH1A1
SCHEMBL1581156 0.86 CYP3A4 (0.67) CYP3A4SLC7A5HRH4HRH3ALDH1A1
SCHEMBL6887974 0.86 CYP3A4 (0.67) CYP3A4SLC7A5HRH4HRH3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11043396-B2 Chemical mechanical polish slurry and method of manufacture TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2021-06-22 US disclosed
US-20200289699-A1 L-HISTIDINE AND VITAMIN B IN OPHTHALMIC SOLUTIONS FXS VENTURES, LLC 2020-09-17 US disclosed
US-RE45587-E1 Vaccines comprising aluminum adjuvants and histidine GLAXOSMITHKLINE BIOLOGICALS SA (BE) 2015-06-30 US disclosed
CN-103429948-A Chemiluminescent device with time delay activation CYALUME TECHNOLOGIES INC 2013-12-04 CN disclosed
US-7754218-B2 pH buffering stability; adjuvant adsorption; reduced antigen hydrolysis Novartis Caccines and Diagnostics SRL (IT) 2010-07-13 US disclosed
CN-101443272-A Methods and compositions for controlled and sustained generation and delivery of peroxides UNIV VIRGINIA COMMONWEALTH (US) 2009-05-27 CN disclosed
US-20080160045-A1 Vaccines Comprising Aluminum Adjuvants and Histidine NOVARTIS VACCINES AND DIAGNOSTICS, S.R.L. (IT) 2008-07-03 US disclosed
US-7348006-B2 Vaccines comprising aluminium adjuvants and histidine NOVARTIS VACCINES AND DIAGNOSTICS, S.R.L. (IT) 2008-03-25 US disclosed
CN-100350972-C Vaccine containing aluminum adjuvant and histidine CHIRON SPA (IT) 2007-11-28 CN disclosed
US-20050158334-A1 Vaccines comprising aluminium adjuvants and histidine GLAXOSMITHKLINE BIOLOGICALS SA (BE) 2005-07-21 US disclosed
CN-1535158-A Vaccines comprising aluminium adjuvants and histidine �����ɷ� 2004-10-06 CN disclosed